Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 Nov;14(5):743–748. doi: 10.1128/aac.14.5.743

Effect of Treatment with 5-Ethyl-2′-Deoxyuridine on Herpes Simplex Virus Encephalitis in Normal and Immunosuppressed Mice

William B Davis 1, John E Oakes 1, John A Taylor 1
PMCID: PMC352544  PMID: 215081

Abstract

5-Ethyl-2′-deoxyuridine (5-ethyl-dUrd), an analog of thymidine, was evaluated for its capacity to inhibit herpes simplex virus (HSV) replication in vitro and in vivo. The 50% effective dose concentration of 5-ethyl-dUrd for HSV types 1 and 2 (HSV-1 and -2) cultured in Vero cells was 6 and 9 μg/ml, respectively. Levels of 5-ethyl-dUrd 14-fold in excess of the 50% effective dose for HSV-1 did not inhibit the formation of confluent monolayers by Vero cells, suggesting that the compound was not cytotoxic or inhibitory for mammalian cells. In vivo studies showed that 5-ethyl-dUrd was effective in significantly reducing mortality when administered to young adult mice after subcutaneous infection with HSV-2. Intraperitoneal and intravenous inoculation of drug (250 mg/kg per day) resulted in a 50% survivor rate at 15 days. Comparative studies with adenine arabinoside at 250 mg/kg per day gave a 40% survivor rate. Intramuscular injection of 5-ethyl-dUrd at a concentration as high as 2,000 mg/kg per day for 10 days was well tolerated by uninfected animals, and HSV-2-infected mice treated at this dosage had a 100% survival rate. Treatment with 5-ethyl-dUrd at a concentration of 500 mg/kg per day significantly increased the mean survival times of HSV-1- and HSV-2-infected mice immunosuppressed by irradiation; however, the fatal course of the infection was not altered. Assay for virus in tissues showed that 5-ethyl-dUrd treatment delayed progression of the infection into the central nervous system, indicating suppression of virus replication in the tissues.

Full text

PDF
743

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cheng Y. C., Goz B., Neenan J. P., Ward D. C., Prusoff W. H. Selective inhibition of herpes simplex virus by 5-amino-2,5-dideoxy-5-iodouridine. J Virol. 1975 May;15(5):1284–1285. doi: 10.1128/jvi.15.5.1284-1285.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. De Clercq E., Shugar D. Antiviral activity of 5-ethyl pyrimidine deoxynucleosides. Biochem Pharmacol. 1975 May 15;24(10):1073–1078. doi: 10.1016/0006-2952(75)90192-6. [DOI] [PubMed] [Google Scholar]
  3. Gauri K. K., Elze K-L Konzentrationsabhängige Wirksamkeit von 5 Athyl-2-desoxyuridin (ADU) bei herpetischen Keratitiden im Tierexperiment und in der Klinik. Klin Monbl Augenheilkd. 1977 Sep;171(3):459–463. [PubMed] [Google Scholar]
  4. Gauri K. K., Malorny G., Riehm E. Einfluss von 5-Athyl-2'-desoxyuridin (ADU) auf die Regeneration der experimentell geschädigten Cornea. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1970;179(4):287–293. doi: 10.1007/BF00427853. [DOI] [PubMed] [Google Scholar]
  5. Gauri K. K., Malorny G., Schiff W. Immunobiological studies with the virostatics 5-ethyl-2'-deoxyuridine (EDU) and 1-allyl-3,5-diethyl-6-chlorouracil (ACIU). Chemotherapy. 1969;14(3):129–132. doi: 10.1159/000220621. [DOI] [PubMed] [Google Scholar]
  6. Gauri K. K., Shif I., Wolford R. G. Failure of 5-ethyl-2'-deoxyuridine to induce oncogenic RNA (oncorna) viruses in Fischer rat embryo cells and in Balb/3T3 mouse cells. Biochem Pharmacol. 1976 Aug 1;25(15):1809–1810. doi: 10.1016/0006-2952(76)90420-2. [DOI] [PubMed] [Google Scholar]
  7. Gauri K. K. Subkonjunktivale Applikation vom 5-Athyl-2'-desoxyuridin (ADU) zur Chemotherapie der experimentellen Herpes-Keratitis beim Kaninchen. Klin Monbl Augenheilkd. 1968;153(6):837–840. [PubMed] [Google Scholar]
  8. Kurtz S. M., Fitzgerald J. E., Schardein J. L. Comparative animal toxicology of vidarabine and its 5'-monophosphate. Ann N Y Acad Sci. 1977 Mar 4;284:6–8. doi: 10.1111/j.1749-6632.1977.tb21931.x. [DOI] [PubMed] [Google Scholar]
  9. Künkel H. A., Gauri K. K., Malorny G. Keine Mutationsauslösung durch 5-Athyl-2'-desoxyuridin (ADU) bei Drosophila melanogaster. Biophysik. 1968 Aug 12;5(1):88–90. doi: 10.1007/BF01388137. [DOI] [PubMed] [Google Scholar]
  10. Lefkowitz E., Worthington M., Conliffe M. A., Baron S. Comparative effectiveness of six antiviral agents in Herpes simplex type 1 infection of mice. Proc Soc Exp Biol Med. 1976 Jul;152(3):337–342. doi: 10.3181/00379727-152-39392. [DOI] [PubMed] [Google Scholar]
  11. Liddell F. D. Evaluation of survival in challenge experiments. Microbiol Rev. 1978 Mar;42(1):237–249. doi: 10.1128/mr.42.1.237-249.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. NICHOLS W. W. IN VITRO CHROMOSOME BREAKAGE INDUCED BY ARABINOSYLADENINE IN HUMAN LEUKOCYTES. Cancer Res. 1964 Sep;24:1502–1505. [PubMed] [Google Scholar]
  13. Nahmias A. J., Shore S. L., Kohl S., Starr S. E., Ashman R. B. Immunology of herpes simplex virus infection: relevance to herpes simplex virus vaccines and cervical cancer. Cancer Res. 1976 Feb;36(2 Pt 2):836–844. [PubMed] [Google Scholar]
  14. Oakes J. E., Hyman R. W., Rapp F. Genome location of polyadenylated transcripts of herpes simplex virus type 1 and type 2 DNA. Virology. 1976 Nov;75(1):145–154. doi: 10.1016/0042-6822(76)90013-1. [DOI] [PubMed] [Google Scholar]
  15. Oakes J. E. Invasion of the central nervous system by herpes simplex virus type 1 after subcutaneous inoculation of immunosuppressed mice. J Infect Dis. 1975 Jan;131(1):51–57. doi: 10.1093/infdis/131.1.51. [DOI] [PubMed] [Google Scholar]
  16. Prusoff W. H., Ward D. C. Nucleoside analogs with antiviral activity. Biochem Pharmacol. 1976 Jun 1;25(11):1233–1239. doi: 10.1016/0006-2952(76)90083-6. [DOI] [PubMed] [Google Scholar]
  17. Ross A. H., Julia A., Balakrishnan C. Toxicity of adenine arabinoside in humans. J Infect Dis. 1976 Jun;133 (Suppl):A192–A198. doi: 10.1093/infdis/133.supplement_2.a192. [DOI] [PubMed] [Google Scholar]
  18. Shipkowitz N. L., Bower R. R., Appell R. N., Nordeen C. W., Overby L. R., Roderick W. R., Schleicher J. B., Von Esch A. M. Suppression of herpes simplex virus infection by phosphonoacetic acid. Appl Microbiol. 1973 Sep;26(3):264–267. doi: 10.1128/am.26.3.264-267.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Singh S., Willers I., Goedde H. W. 5-Ethyl-2'-deoxyuridine: absence of effects on the chromosomes of human lymphocytes and fibroblasts in culture. Humangenetik. 1974;24(2):135–139. doi: 10.1007/BF00283770. [DOI] [PubMed] [Google Scholar]
  20. Steele R. W., Chapa I. A., Vincent M. M., Hensen S. A., Keeney R. E. Effects of adenine arabinoside on cellular immune mechanisms in humans. Antimicrob Agents Chemother. 1975 Feb;7(2):203–207. doi: 10.1128/aac.7.2.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Swierkowska K. M., Jasińska J. K., Steffen J. A. 5-Ethyl-2'-deoxyuridine: evidence for incorporation into DNA and evaluation of biological properties in lymphocyte cultures grown under conditions of amethopterine-imposed thymidine deficiency. Biochem Pharmacol. 1973 Jan 1;22(1):85–93. doi: 10.1016/0006-2952(73)90257-8. [DOI] [PubMed] [Google Scholar]
  22. Swierkowski M., Shugar D. A nonmutagenic thymidine analog with antiviral activity. 5-Ethyldeoxyuridine. J Med Chem. 1969 May;12(3):533–534. doi: 10.1021/jm00303a617. [DOI] [PubMed] [Google Scholar]
  23. Whitley R. J., Soong S. J., Dolin R., Galasso G. J., Ch'ien L. T., Alford C. A. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977 Aug 11;297(6):289–294. doi: 10.1056/NEJM197708112970601. [DOI] [PubMed] [Google Scholar]
  24. Worthington M. G., Conliffe M., Williams J. Treatment of fatal disseminated herpes simplex virus, type 1, infection in immunosuppressed mice (39899). Proc Soc Exp Biol Med. 1977 Oct;156(1):168–172. doi: 10.3181/00379727-156-39899. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES